A multicenter prospective randomized trial of corticosteroids in primary therapy for Kawasaki disease: Clinical course and coronary artery outcome
- 30 September 2006
- journal article
- research article
- Published by Elsevier BV in The Journal of Pediatrics
- Vol. 149 (3), 336-341.e1
- https://doi.org/10.1016/j.jpeds.2006.05.025
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Efficacy of intravenous immune globulin therapy combined with dexamethasone for the initial treatment of acute Kawasaki diseaseEuropean Journal of Pediatrics, 2004
- Advances in Kawasaki diseaseEuropean Journal of Pediatrics, 2004
- Ulinastatin, an Elastase Inhibitor, Inhibits the Increased mRNA Expression of Prostaglandin H2Synthase–Type 2 in Kawasaki DiseaseThe Journal of Infectious Diseases, 2000
- Cytokines predict coronary aneurysm formation in Kawasaki disease patientsEuropean Journal of Pediatrics, 1993
- Serial changes of serum interleukin-6, interleukin-8, and tumor necrosis factor alpha among patients with Kawasaki diseaseThe Journal of Pediatrics, 1992
- Intravenous γ‐Globulin Treatment in Kawasaki DiseasePediatrics International, 1991
- The changes of interleukin-2, tumour necrotic factor and gamma-interferon production among patients with Kawasaki diseaseEuropean Journal of Pediatrics, 1991
- Serum levels of tumor necrosis factor, interleukin 2 receptor, and interferon-γ in Kawasaki disease involved coronary-artery lesionsClinical Immunology and Immunopathology, 1990
- The Treatment of Kawasaki Syndrome with Intravenous Gamma GlobulinThe New England Journal of Medicine, 1986
- HIGH-DOSE INTRAVENOUS GAMMAGLOBULIN FOR KAWASAKI DISEASEThe Lancet, 1984